EUVIMEDDescoperă EUVIMED
Crossref

Effect of curcumin on inhibiting atherogenesis by down-regulating lipocalin-2 expression in apolipoprotein E knockout mice

Qiang Wan, Zhong-Yong Liu, Yu-Ping Yang, Shi-Ming Liu

Bio-Medical Materials and Engineering · 2017-02-21 · 27 (6) · 577-587

DOI: 10.3233/bme-161610 ↗

At a glance

Journal article in Bio-Medical Materials and Engineering, published on 2017-02-21. Written by Qiang Wan and 3 co-authors. Institution: Department of Medical Cardiology, Affiliated Hospital, Jiangxi University of Traditional Chinese Medicine, Nanchang, China. Major MEDLINE topics: Down-Regulation. Cited 11 times so far (Crossref); 26 references.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

BACKGROUND: Curcumin possesses significant anti-atherosclerosis properties. Lipocalin-2 (LCN2) is already known as one of the most promising biomarkers of atherosclerosis. However, research on the effect of curcumin on regulating LCN2 expression in atherogenesis is very limited. The aim of the study was to investigate whether curcumin could alleviate atherosclerosis in ApoE-/- mice by down-regulating LCN2 expression. METHODS: Fifty apolipoprotein E knockout (ApoE-/-) mice were fed with a western diet for 12 weeks and randomly divided into five groups: model group (Mod), positive control group (Lov, with 30 mg/kg/d lovastatin), three curcumin groups (CurL, CurM and CurH, with 40, 60 and 80 mg/kg/d curcumin), while 10 C57BL/6J mice were fed with a standard mouse chow diet as a control group (Con). LCN2 in serum and aorta, biomarkers of serum lipid and inflammation were determined and the plaque area of the atherosclerosis lesions was quantified. RESULTS: CurM and CurH group were significantly lower than Mod group in terms of serum LCN2, lipid and inflammatory cytokine levels, plaque area and LCN2 expression in atherosclerotic lesions, similar to lovastatin treatment. CONCLUSIONS: Our findings indicate that dietary curcumin ameliorates western diet-induced atherosclerosis in ApoE-/- mice, which is related to LCN2 down-regulation, anti-hyperlipidemia effect as well as the inhibition of inflammation.

Subjects

MeSH terms (MEDLINE)

Down-RegulationAnimalsAortaApolipoproteins EAtherosclerosisBiomarkersC-Reactive ProteinCholesterol, HDLCholesterol, LDLCurcuminDiet, WesternHydrogen-Ion ConcentrationImmunohistochemistryInterleukin-6Lipocalin-2MaleMiceMice, Inbred C57BLMice, KnockoutPlaque, AtheroscleroticTriglycerides

Author keywords

Curcuminanti-hyperlipidemiaapolipoprotein E knockout (ApoE−/−) miceatherosclerosisinflammationlipocalin-2 (LCN2)

Substances

Apolipoproteins EBiomarkersCholesterol, HDLCholesterol, LDLInterleukin-6Lipocalin-2TriglyceridesTumor Necrosis Factor-alphaLcn2 protein, mouseC-Reactive Protein

Authors and institutions

  • Department of Medical Cardiology, Affiliated Hospital, Jiangxi University of Traditional Chinese Medicine, Nanchang, China.
  • Institute of Cardiovascular Disease, Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.

Cite

APA

Wan, Q., Liu, Z. Y., Yang, Y. P., & Liu, S. M. (2017). Effect of curcumin on inhibiting atherogenesis by down-regulating lipocalin-2 expression in apolipoprotein E knockout mice. Bio-Medical Materials and Engineering, 27(6), 577-587. https://doi.org/10.3233/bme-161610

Vancouver

Wan Q, Liu ZY, Yang YP, Liu SM. Effect of curcumin on inhibiting atherogenesis by down-regulating lipocalin-2 expression in apolipoprotein E knockout mice. Bio-Medical Materials and Engineering. 2017;27(6):577-587. doi:10.3233/bme-161610

BibTeX
@article{Wan2017,
  author = {Wan, Qiang and Liu, Zhong-Yong and Yang, Yu-Ping and Liu, Shi-Ming},
  title = {Effect of curcumin on inhibiting atherogenesis by down-regulating lipocalin-2 expression in apolipoprotein E knockout mice},
  journal = {Bio-Medical Materials and Engineering},
  year = {2017},
  volume = {27},
  number = {6},
  pages = {577--587},
  doi = {10.3233/bme-161610}
}
Start for free →